Antithrombotische Therapie bei Patienten mit Koronarstent und Vorhofflimmern
Authors:
- Martin MoserMMMartin Moser
- Christoph BodeCBChristoph Bode
- 17 March 2021
- journal article
- thrombozyten und-gerinnungssystem
- Published by Georg Thieme Verlag KG in Kardiologie up2date
- Vol. 17 (01) , 55-65
Abstract
Die Auswahl eines geeigneten antithrombotischen Regimes für Patienten mit Vorhofflimmern, die sich einer perkutanen Koronarintervention unterziehen müssen, ist in dieser kombinierten Indikation schwierig und mit potenziellen Problemen in Hinblick auf das thrombembolische und Blutungsrisiko behaftet. Dieser Beitrag gibt einen Überblick über die aktuellen Therapieempfehlungen für diese kritische Patientengruppe. Publication Date: 17 March 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyKeywords
This publication has 22 references indexed in Scilit:
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCINew England Journal of Medicine, 2016
- Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent CandidatesJACC, 2015
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- New‐Onset Atrial Fibrillation is Associated With Cardiovascular Events Leading to Death in a First Time Myocardial Infarction Population of 89 703 Patients With Long‐Term Follow‐Up: A Nationwide StudyJournal of the American Heart Association, 2014
- A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General RegistryEP Europace, 2013
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trialThe Lancet, 2013
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialThe Lancet, 2006
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingNew England Journal of Medicine, 1998
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996